Doulamis Ilias P, Guariento Alvise, Duignan Thomas, Orfany Arzoo, Kido Takashi, Zurakowski David, Del Nido Pedro J, McCully James D
Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Eur J Cardiothorac Surg. 2020 May 1;57(5):836-845. doi: 10.1093/ejcts/ezz326.
Type 2 diabetes causes mitochondrial dysfunction, which increases myocardial susceptibility to ischaemia-reperfusion injury. We investigated the efficacy of transplantation of mitochondria isolated from diabetic or non-diabetic donors in providing cardioprotection from warm global ischaemia and reperfusion in the diabetic rat heart.
Ex vivo perfused hearts from Zucker diabetic fatty (ZDF fa/fa) rats (n = 6 per group) were subjected to 30 min of warm global ischaemia and 120 min reperfusion. Immediately prior to reperfusion, vehicle alone (VEH) or vehicle containing mitochondria isolated from either ZDF (MTZDF) or non-diabetic Zucker lean (ZL +/?) (MTZL) skeletal muscle were delivered to the coronary arteries via the aortic cannula.
Following 30-min global ischaemia and 120-min reperfusion, left ventricular developed pressure was significantly increased in MTZDF and MTZL groups compared to VEH group (MTZDF: 92.8 ± 5.2 mmHg vs MTZL: 110.7 ± 2.4 mmHg vs VEH: 44.3 ± 5.9 mmHg; P < 0.01 each); and left ventricular end-diastolic pressure was significantly decreased (MTZDF 12.1 ± 1.3 mmHg vs MTZL 8.6 ± 0.8 mmHg vs VEH: 18.6 ± 1.5 mmHg; P = 0.016 for MTZDF vs VEH and P < 0.01 for MTZL vs VEH). Total tissue ATP content was significantly increased in both MT groups compared to VEH group (MTZDF: 18.9 ± 1.5 mmol/mg protein/mg tissue vs MTZL: 28.1 ± 2.3 mmol/mg protein/mg tissue vs VEH: 13.1 ± 0.5 mmol/mg protein/mg tissue; P = 0.018 for MTZDF vs VEH and P < 0.01 for MTZL vs VEH). Infarct size was significantly decreased in the MT groups (MTZDF: 11.8 ± 0.7% vs MTZL: 9.9 ± 0.5% vs VEH: 52.0 ± 1.4%; P < 0.01 each).
Mitochondrial transplantation significantly enhances post-ischaemic myocardial functional recovery and significantly decreases myocellular injury in the diabetic heart.
2型糖尿病会导致线粒体功能障碍,增加心肌对缺血再灌注损伤的易感性。我们研究了移植从糖尿病或非糖尿病供体分离的线粒体,对糖尿病大鼠心脏在温暖性全心缺血和再灌注过程中提供心脏保护的效果。
将来自Zucker糖尿病肥胖(ZDF fa/fa)大鼠(每组n = 6)的离体灌注心脏进行30分钟的温暖性全心缺血和120分钟的再灌注。在再灌注前即刻,通过主动脉插管将单独的载体(VEH)或含有从ZDF(MTZDF)或非糖尿病Zucker瘦鼠(ZL +/?)(MTZL)骨骼肌分离的线粒体的载体注入冠状动脉。
在30分钟全心缺血和120分钟再灌注后,与VEH组相比,MTZDF组和MTZL组的左心室舒张末压显著升高(MTZDF:92.8±5.2 mmHg,MTZL:110.7±2.4 mmHg,VEH:44.3±5.9 mmHg;每组P < 0.01);左心室舒张末压显著降低(MTZDF 12.1±1.3 mmHg,MTZL 8.6±0.8 mmHg,VEH:18.6±1.5 mmHg;MTZDF与VEH相比P = 0.016,MTZL与VEH相比P < 0.01)。与VEH组相比,两个MT组的总组织ATP含量均显著增加(MTZDF:18.9±1.5 mmol/mg蛋白质/mg组织,MTZL:28.1±2.3 mmol/mg蛋白质/mg组织,VEH:13.1±0.5 mmol/mg蛋白质/mg组织;MTZDF与VEH相比P = 0.018,MTZL与VEH相比P < 0.01)。MT组的梗死面积显著减小(MTZDF:11.8±0.7%,MTZL:9.9±0.5%,VEH:52.0±1.4%;每组P < 0.01)。
线粒体移植可显著增强缺血后心肌功能恢复,并显著减少糖尿病心脏的心肌细胞损伤。